- Drug Manufacturers - General
- Healthcare
Merck & Co., Inc.
MRK · US ·
NYSE
114.55
USD
+0.63
(0.55%)
-
5.42
EPS
-
21.13
P/E
-
290B
MARKET CAP
-
2.65%
DIV YIELD
EPS Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 5.59 | 8.43 | 9.62 | 11.1 | 11.8 | 11.8 | 16.17% |
| Avg. Estimate | 5.42 | 8.04 | 9.02 | 10 | 11.4 | 11.5 | 16.17% |
| Low Estimate | 5.22 | 7.74 | 7.92 | 8.34 | 11 | 11.1 | 16.17% |
| No. Of Analysts | 14 | 14 | 13 | 12 | 5 | 6 |
Revenue Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 62.8B | 64.4B | 71.7B | 74.6B | 76.8B | 77.6B | 4.31% |
| Avg. Estimate | 62.5B | 64.2B | 68.6B | 72.8B | 75B | 75.8B | 3.94% |
| Low Estimate | 62.3B | 64B | 65.3B | 70.8B | 72.9B | 73.7B | 3.40% |
| No. Of Analysts | 18 | 12 | 16 | 22 | 12 | 10 |
Net Income Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 16.5B | 21.5B | 24.5B | 28.2B | 30.1B | 30.1B | 12.81% |
| Avg. Estimate | 13.7B | 20.5B | 22.8B | 25.6B | 29.2B | 29.2B | 16.28% |
| Low Estimate | 11B | 19.7B | 20.2B | 21.2B | 28.1B | 28.1B | 20.69% |
| No. Of Analysts | 18 | 12 | 16 | 22 | 12 | 10 |